Outlook Therapeutics files a BLA for Lytenava (bevacizumab-vikg) for treating wet age-related macular degeneration.
Medtronic recalls a subset of IN.Pact Admiral and IN.Pact AV paclitaxel-coated percutaneous transluminal angioplasty balloon catheters due to the pote...
FDA says patients and healthcare professionals should not use drugs purporting to be sterile produced by Richardson, TX-based FarmaKeio Superior Custo...
FDA and the FTC warn seven companies they are selling unapproved and misbranded drugs containing cannabidiol as Covid-19 treatments.
ORA Office of Pharmaceutical Quality Operations director Alonza Cruse says FDA is beginning its long-planned pilot program to measure the impact of an...
FDA commissioner Robert Califf and chief information officer Vid Desai provide an overview of the agencys progress in data and technology modernizatio...
FDA says Teva is recalling one lot of its leukemia drug IDArubicin hydrochloride injection due to the presence of particulate matter found in one vial...
Federal Register notice: FDA extends the comment period of a 1/13 Federal Register notice seeking input on scientific data and information related to ...